Clinical trial enrollment has long been a bottleneck in drug development
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
The innovation -- UPM Circular Renewable Black -- is the world’s first bio-based, near-infrared (NIR) detectable, carbon-negative black
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
The product will be marketed by Dr. Reddy's Laboratories Inc.
Glenmark's Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial is bioequivalent and therapeutically equivalent to the reference listed drug
Subscribe To Our Newsletter & Stay Updated